Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

214.34
Delayed Data
As of Jan 20
 -0.24 / -0.11%
Today’s Change
184.50
Today|||52-Week Range
301.98
+2.06%
Year-to-Date
How Will Pfizer Inc. Fare Under President Trump?
Jan 21 / MotleyFool.com - Paid Partner Content
Frontrunning: January 18
Jan 18 / Investing Channel - Paid Partner Content
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
Jan 20 / Zacks.com - Paid Partner Content
Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions
Jan 18 / TheStreet.com - Paid Partner Content
Clear Harbor Asset Management, LLC Buys General Motors Co, Qorvo Inc, Toll Brothers I...
Jan 20 / GuruFocus News - Paid Partner Content
Today's Trade
Jan 17 / TheStreet.com - Paid Partner Content
Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon
Jan 20 / TheStreet.com - Paid Partner Content
Intermede Investment Partners Ltd Buys Wells Fargo & Co, Facebook Inc, Amgen Inc, Sel...
Jan 17 / GuruFocus News - Paid Partner Content
Synergy Pharmaceuticals Secures Approval for Linzess Competitor
Jan 20 / TheStreet.com - Paid Partner Content
Biotech Sector to See M&A, Earnings Action
Jan 17 / TheStreet.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
Jan 13 / Zacks.com - Paid Partner Content
Should Value Investors Choose Allergan (AGN)?
Jan 19 / Zacks.com - Paid Partner Content
Biotechs stage recovery from Trump line of fire
Jan 12 / FT.com - Paid Partner Content
Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan 19 / Zacks.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
Jan 19 / Zacks.com - Paid Partner Content
Trump: Drug companies 'getting away with murder'
Jan 11 / CNNMoney.com
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
Jan 19 / Zacks.com - Paid Partner Content
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
Jan 10 / MotleyFool.com - Paid Partner Content
Allergan's Uterine Fibroids Candidate Positive in Phase III
Jan 18 / Zacks.com - Paid Partner Content
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
Jan 09 / Zacks.com - Paid Partner Content
Horan Capital Management Buys Berkshire Hathaway Inc, Allergan PLC, Gilead Sciences I...
Jan 18 / GuruFocus News - Paid Partner Content
Teva Falls on Disappointing 2017 Sales & Earnings Guidance
Jan 09 / Zacks.com - Paid Partner Content
Not Allergic to AGN
Jan 18 / TheStreet.com - Paid Partner Content